Tag: CORO
BCG Vaccine Does Not Reduce COVID-19 Risk for Health Care Workers
No significant difference seen in risk for symptomatic COVID-19, severe COVID-19 for those receiving BCG or saline placebo
Adverse Events Detailed for Teen COVID-19 Vaccination Program
Overall, 17.7 cases of myocarditis reported per million vaccinations; 77 percent had symptom resolution at time of report
Discrimination in Health Care Linked to Nonvaccination Against COVID-19
Reported experiences of racial and ethnic discrimination linked to difference in prevalence of nonvaccination
Dexamethasone Still Beneficial for Some Inpatients With COVID-19
Odds of mortality or discharge to hospice reduced for those receiving supplemental oxygen or mechanical ventilation and/or ECMO
COVID-19 Vaccines Effective Against Moderate, Severe Disease in Children, Teens
Vaccine effectiveness waned significantly after ≥150 days during the omicron variant phase
Amubarvimab Plus Romlusevimab Safe, Effective for COVID-19
Reduces risk for hospitalizations and/or deaths for nonhospitalized patients at high risk for clinical progression
SARS-CoV-2 Infection Linked to Increased Risk for Diabetes
Fraction of incident diabetes cases attributable to SARS-CoV-2 infection was 3.41 percent overall, 4.75 percent among men
Oral Fluvoxamine Plus Budesonide Cuts Severe Disease in COVID-19
Reduction in incidence of severe disease requiring advanced care seen among high-risk outpatients with COVID-19
FDA Authorizes Spring COVID-19 Booster for Certain Americans
Original mRNA vaccines are being pulled from the market in favor of the bivalent vaccines, which target both the omicron variant and the original strain of COVID-19
COVID-19 Vaccines Do Not Increase Risk for New Retinal Vascular Occlusion
Rates within 21 days of vaccination extremely rare and similar to those with influenza and Tdap vaccines
